111 Capital Buys New Holdings in Omega Healthcare Investors, Inc. $OHI

Key Points

• 111 Capital has acquired a new stake in Omega Healthcare Investors, Inc., purchasing 21,921 shares valued at approximately $803,000.
• Equity analysts have shown optimism with several raising their price targets for Omega Healthcare Investors, with an average target now at $44.44 and multiple "Buy" ratings issued.
• Omega Healthcare declared a quarterly dividend of $0.67, representing an annualized dividend yield of 6.5%.

111 Capital bought a new stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 21,921 shares of the real estate investment trust's stock, valued at approximately $803,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. NBC Securities Inc. bought a new stake in Omega Healthcare Investors during the 1st quarter valued at approximately $29,000. MassMutual Private Wealth & Trust FSB raised its stake in Omega Healthcare Investors by 562.3% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,828 shares of the real estate investment trust's stock valued at $67,000 after purchasing an additional 1,552 shares during the period. Register Financial Advisors LLC bought a new stake in Omega Healthcare Investors during the 2nd quarter valued at approximately $73,000. UMB Bank n.a. raised its stake in Omega Healthcare Investors by 94.9% during the 1st quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust's stock valued at $83,000 after purchasing an additional 1,059 shares during the period. Finally, Trust Co. of Vermont bought a new stake in Omega Healthcare Investors during the 2nd quarter valued at approximately $95,000. Institutional investors own 65.25% of the company's stock.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Scotiabank raised their price target on Omega Healthcare Investors from $39.00 to $42.00 and gave the company a "sector perform" rating in a report on Thursday, August 28th. Cantor Fitzgerald assumed coverage on Omega Healthcare Investors in a report on Wednesday. They set an "overweight" rating and a $50.00 price target for the company. Weiss Ratings restated a "buy (b)" rating on shares of Omega Healthcare Investors in a report on Saturday, September 27th. Truist Financial raised their price target on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a report on Wednesday, September 3rd. Finally, Wells Fargo & Company raised their price target on Omega Healthcare Investors from $41.00 to $44.00 and gave the company an "overweight" rating in a report on Wednesday, August 27th. Seven investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $44.44.

Omega Healthcare Investors Price Performance

Shares of Omega Healthcare Investors stock opened at $41.13 on Friday. The stock has a market cap of $12.13 billion, a price-to-earnings ratio of 25.39, a price-to-earnings-growth ratio of 2.15 and a beta of 0.70. The company has a debt-to-equity ratio of 0.96, a quick ratio of 7.10 and a current ratio of 7.10. The stock has a 50 day moving average price of $41.42 and a 200-day moving average price of $38.71. Omega Healthcare Investors, Inc. has a one year low of $35.04 and a one year high of $44.42.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, topping analysts' consensus estimates of $0.45 by $0.32. The firm had revenue of $235.60 million during the quarter, compared to analysts' expectations of $248.49 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The company's quarterly revenue was up 11.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Equities analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were issued a $0.67 dividend. The ex-dividend date was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.5%. Omega Healthcare Investors's payout ratio is 165.43%.

Insider Activity at Omega Healthcare Investors

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $40.16, for a total value of $100,400.00. Following the completion of the transaction, the director owned 18,654 shares in the company, valued at approximately $749,144.64. The trade was a 11.82% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.50% of the company's stock.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.